50242-201Level 3
Lunsumio Velo (Mosunetuzumab)
**Product type:** Human Prescription Drug
**Active ingredient:** MOSUNETUZUMAB
**Strength:** 45 mg/mL
**Dosage form:** Injection
**Route:** Subcutaneous
**Labeler:** Genentech, Inc.
**Marketing category:** BLA (BLA761263)
GET
/api/v1/systems/ndc_fda/nodes/50242-201Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.